Abstract
The potential and limitations of the non classical metallodrugs with platinum as metal are discussed in this section, focusing not only in their design but in their mechanism of action and interaction with other biomolecules to introduce and encourage the readers on the potential of this field.
Keywords: Metallodrugs, platinum, biomolecules binding, non classical metallodrugs, biomolecules, Current Platinum Complexes, Antitumor Drugs, platinum drugs and their structure-activity relationship, Cisplatin, metallodrug design, platinum chemotherapy, antitumor activity, RULE-BREAKERS, ”, TRANS-PLATINUM COMPLEXES
Current Topics in Medicinal Chemistry
Title: Non-Classical Structures Among Current Platinum Complexes with Potential as Antitumor Drugs
Volume: 11 Issue: 21
Author(s): Adoracion G. Quiroga
Affiliation:
Keywords: Metallodrugs, platinum, biomolecules binding, non classical metallodrugs, biomolecules, Current Platinum Complexes, Antitumor Drugs, platinum drugs and their structure-activity relationship, Cisplatin, metallodrug design, platinum chemotherapy, antitumor activity, RULE-BREAKERS, ”, TRANS-PLATINUM COMPLEXES
Abstract: The potential and limitations of the non classical metallodrugs with platinum as metal are discussed in this section, focusing not only in their design but in their mechanism of action and interaction with other biomolecules to introduce and encourage the readers on the potential of this field.
Export Options
About this article
Cite this article as:
G. Quiroga Adoracion, Non-Classical Structures Among Current Platinum Complexes with Potential as Antitumor Drugs, Current Topics in Medicinal Chemistry 2011; 11 (21) . https://dx.doi.org/10.2174/156802611798040723
DOI https://dx.doi.org/10.2174/156802611798040723 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Engineered Peptides for Applications in Cancer-Targeted Drug Delivery and Tumor Detection
Mini-Reviews in Medicinal Chemistry Peptides and Small Molecules Targeting the Plasminogen Activation System: Towards Prophylactic Anti-Metastasis Drugs for Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers
Current Drug Metabolism Monofunctional Platinum (PtII) Compounds – Shifting the Paradigm in Designing New Pt-based Anticancer Agents
Current Medicinal Chemistry Rationale for an Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer
Recent Patents on Anti-Cancer Drug Discovery Antineoplastic Activity of Monocrotaline Against Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry A Fresh Prospect of Extracellular Matrix Hydrolytic Enzymes and Their Substrates
Current Pharmaceutical Design Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy
Current Drug Delivery Radiolabelling of Ascorbic Acid: A New Clue to Clarify its Action as an Anticancer Agent?
Current Radiopharmaceuticals Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy
Current Genomics Recent Advances, Issues and Patents on Medical Nanorobots
Recent Patents on Engineering Targeting EZH2 for Cancer Therapy: Progress and Perspective
Current Protein & Peptide Science The Impact of Thrombopoietin on Clinical Practice
Current Pharmaceutical Design Meet Our Editorial Board Member
Reviews on Recent Clinical Trials Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling
Current Cancer Drug Targets Anti-tumor Activity of Propofol: A Focus on MicroRNAs
Current Cancer Drug Targets iPSCs Derived from Malignant Tumor Cells: Potential Application for Cancer Research
Current Stem Cell Research & Therapy Identification of Disease States and Response to Therapy in Humans by Utilizing the Biomarker EGFR for Targeted Molecular Imaging
Current Protein & Peptide Science Jatrorrhizine Protects Against Okadaic Acid Induced Oxidative Toxicity Through Inhibiting the Mitogen-Activated Protein Kinases Pathways in HT22 Hippocampal Neurons
CNS & Neurological Disorders - Drug Targets Immunomodulation and Anti-inflammatory Roles of Polyphenols as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry